DHAMPUR BIO ORGANICS Latest Share Price (DBOL)
TODAY IN ONE LINE
DBOL edged up 0.4% on above-average volume (1780911.8x avg), in line with Nifty's 0.3% move.
With a market cap of ₹776.73 Cr., it trades at a P/E of 9.49. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
DHAMPUR BIO ORGANICS flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Steady Dividend YieldReliable 1.28% dividend yield
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Sales ContractionQuarterly sales dropped 2.2% YoY
- ●Poor Capital ReturnsLow ROE of 2.5%
- ●Low Promoter HoldingPromoters hold only 1.0%
- ●Promoter SellingPromoter holding decreased by 49.63% QoQ
Latest DHAMPUR BIO ORGANICS News
What changed recently?
Recent events, corporate actions, and announcements.
DHAMPUR BIO ORGANICS valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for DHAMPUR BIO ORGANICS, framed against the sector median so the premium or discount is obvious at a glance.
DHAMPUR BIO ORGANICS trades at a P/E of 9.49× and P/B of 0.78×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
DHAMPUR BIO ORGANICS technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for DHAMPUR BIO ORGANICS — derived from the latest tape, not yesterday's close.
DHAMPUR BIO ORGANICS last traded at ₹116.27 with an intraday range of ₹109.74–₹117.3 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹116.27| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 134.25 | +17.98 | +15.47% |
| R3 | 126.69 | +10.42 | +8.96% |
| R2 | 122.00 | +5.73 | +4.93% |
| R1 | 119.13 | +2.86 | +2.46% |
| PIVOT | 114.44 | -1.83 | -1.58% |
| CURRENT | 116.27 | — | — |
| S1 | 111.57 | -4.70 | -4.04% |
| S2 | 106.88 | -9.39 | -8.08% |
| S3 | 104.01 | -12.26 | -10.54% |
| S4 | 96.45 | -19.82 | -17.04% |
DBOL is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹113.23–₹117.3
Trading Inside opening range
DHAMPUR BIO ORGANICS financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for DHAMPUR BIO ORGANICS — consolidated or standalone — with margins, YoY growth and key ratios inline.
DHAMPUR BIO ORGANICS reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹776.73 Cr. and reported EPS of ₹5.54.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 2,693 | 3,133 ▲ 16.4% |
| Sales Growth YoY %Derived | 12.47% | 16.35% |
| Other Income | 4 | 32 ▲ 769.7% |
| Total Income | 2,697 | 3,165 ▲ 17.4% |
| 1,385 | 1,598 ▲ 15.4% | |
| Gross ProfitDerived | 1,308 | 1,535 ▲ 17.4% |
| Gross Margin %Derived | 48.57% | 48.99% |
| 1,173 | 1,404 ▲ 19.7% | |
| EBITDA (Operating Profit)Derived | 135 | 131 ▼ 2.9% |
| OPM %Derived | 5.01% | 4.18% |
| 119 | 122 ▲ 2.1% | |
| Profit Before Tax (PBT) | 16 | 41 ▲ 160.3% |
| 1 | 16 ▲ 1441.2% | |
| Effective Tax %Derived | 6.49% | 38.44% |
| Total Profit for Period | 15 | 25 ▲ 71.4% |
| Net Profit (Owner's PAT)Derived | 15 | 25 ▲ 71.4% |
| Net Profit Margin %Derived | 0.55% | 0.80% |
| PAT Growth YoY %Derived | -68.40% | 71.41% |
| Earnings Per Share (EPS ₹) | 6.75 | 3.79 ▼ 43.9% |
| Diluted Shares Outstanding (Cr) | 7 | 7 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | 2 | 3 ▲ 31.0% |
| Total Expenses (incl. D&A & Interest) | 2,681 | 3,124 ▲ 16.5% |
| Material Cost % of RevenueDerived | 50.58% | 47.08% |
| Employee Cost % of RevenueDerived | 3.74% | 3.62% |
| Other Cost % of RevenueDerived | 39.82% | 41.19% |
| Interest Coverage (x)Derived | 1.21x | 1.14x |
| Period | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|
| Revenue from Operations | 2,654 | 2,394 ▼ 9.8% | 2,693 ▲ 12.5% | 3,133 ▲ 16.4% | |
| Sales Growth YoY %Derived | — | -9.80% | 12.47% | 16.35% | |
| Other Income | 11 | 24 ▲ 109.0% | 4 ▼ 84.7% | 32 ▲ 769.7% | |
| Total Income | 2,666 | 2,418 ▼ 9.3% | 2,697 ▲ 11.5% | 3,165 ▲ 17.4% | |
1,836 | 1,371 ▼ 25.3% | 1,385 ▲ 1.1% | 1,598 ▲ 15.4% | ||
| Gross ProfitDerived | 818 | 1,024 ▲ 25.1% | 1,308 ▲ 27.8% | 1,535 ▲ 17.4% | |
| Gross Margin %Derived | 30.83% | 42.76% | 48.57% | 48.99% | |
614 | 887 ▲ 44.6% | 1,173 ▲ 32.2% | 1,404 ▲ 19.7% | ||
| EBITDA (Operating Profit)Derived | 205 | 136 ▼ 33.4% | 135 ▼ 1.2% | 131 ▼ 2.9% | |
| OPM %Derived | 7.71% | 5.70% | 5.01% | 4.18% | |
81 | 95 ▲ 16.5% | 119 ▲ 25.8% | 122 ▲ 2.1% | ||
| Profit Before Tax (PBT) | 135 | 65 ▼ 51.4% | 16 ▼ 76.0% | 41 ▲ 160.3% | |
24 | 19 ▼ 19.7% | 1 ▼ 94.6% | 16 ▲ 1441.2% | ||
| Effective Tax %Derived | 17.56% | 29.01% | 6.49% | 38.44% | |
| Total Profit for Period | 111 | 46 ▼ 58.2% | 15 ▼ 68.4% | 25 ▲ 71.4% | |
| Net Profit (Owner's PAT)Derived | 111 | 46 ▼ 58.2% | 15 ▼ 68.4% | 25 ▲ 71.4% | |
| Net Profit Margin %Derived | 4.19% | 1.94% | 0.55% | 0.80% | |
| PAT Growth YoY %Derived | — | -58.15% | -68.40% | 71.41% | |
| Earnings Per Share (EPS ₹) | 16.74 | 7.00 ▼ 58.2% | 6.75 ▼ 3.6% | 3.79 ▼ 43.9% | |
| Diluted Shares Outstanding (Cr) | 7 | 7 ▲ 0.0% | 7 ▲ 0.0% | 7 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | -1 | -1 ▲ 17.7% | 2 ▲ 318.3% | 3 ▲ 31.0% | |
| Total Expenses (incl. D&A & Interest) | 2,531 | 2,353 ▼ 7.0% | 2,681 ▲ 13.9% | 3,124 ▲ 16.5% | |
| Material Cost % of RevenueDerived | 59.83% | 66.99% | 50.58% | 47.08% | |
| Employee Cost % of RevenueDerived | 4.07% | 4.04% | 3.74% | 3.62% | |
| Other Cost % of RevenueDerived | 19.05% | 33.02% | 39.82% | 41.19% | |
| Interest Coverage (x)Derived | 4.02x | 1.92x | 1.21x | 1.14x |
DHAMPUR BIO ORGANICS segment analysis : revenue and profit mix.
Disclosed business segments at DHAMPUR BIO ORGANICS with their share of revenue and profit, switchable between consolidated and standalone reporting.
DHAMPUR BIO ORGANICS discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for DHAMPUR BIO ORGANICS.
Our AI distills the core fundamental drivers supporting DHAMPUR BIO ORGANICS, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
DHAMPUR BIO ORGANICS's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Promoter holding of 50.79% demonstrates strong founder commitment and governance stability.
Latest quarterly revenue growth of 22.86% YoY shows underlying demand and market traction.
TTM revenue growth of 72.27% YoY indicates significant top-line expansion over trailing twelve months.
Stock trading at 0.76x price-to-book suggests potential undervaluation relative to asset base.
Diversified product portfolio spanning sugar, bio-fuels, spirits, and renewable energy reduces commodity risk.
Key Risks.
TTM EPS of -1.15 reflects severe profitability deterioration and negative shareholder value creation.
Return on Equity of 2.45% and ROCE of 3.24% indicate extremely poor capital efficiency versus peers.
Latest quarterly net loss of ₹220 Cr with diluted EPS of -3.31 signals acute operational distress.
Total debt of ₹1,054.17 Cr against market cap of ₹827.85 Cr creates elevated financial leverage risk.
Operating margin of 3.32% is critically thin, leaving minimal buffer for cost or commodity pressures.
Flip Conditions.
Valuation risk. a P/E above 12 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.53. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
DHAMPUR BIO ORGANICS peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — DHAMPUR BIO ORGANICS is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
DHAMPUR BIO ORGANICS chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for DHAMPUR BIO ORGANICS — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
DHAMPUR BIO ORGANICS delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for DHAMPUR BIO ORGANICS over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in DHAMPUR BIO ORGANICS stood at 54.8% of traded volume, against a 20-day average of 50.8%.
DHAMPUR BIO ORGANICS announcements: results, concalls, ratings, M&A.
Filings DHAMPUR BIO ORGANICS sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
DHAMPUR BIO ORGANICS files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 96 documents below.
Credit Rating
Dhampur Bio Organics Limited has informed the Exchange about Credit Rating
General Updates
Dhampur Bio Organics Limited has informed the Exchange about Intimation of Payment of Final Dividend for the Financial Year 2025-26
Resignation of Director/KMP/SMP
Dhampur Bio Organics Limited has informed the Exchange about Resignation of Director/KMP/SMP
Cessation
Dhampur Bio Organics Limited has informed the Exchange regarding Cessation of Mr. Lalit Dalal as Vice President - Finance and Accounts of the…
Shareholders meeting
Dhampur Bio Organics Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 24, 2026. Further, the…
Investor decks & rating reports.
Investor Presentation
Investor Presentation
Investor Presentation
General Updates
Investor Presentation
Investor Presentation
DHAMPUR BIO ORGANICS dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue DHAMPUR BIO ORGANICS has declared, sequenced by announce and record date.
DHAMPUR BIO ORGANICS corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
DHAMPUR BIO ORGANICS insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in DHAMPUR BIO ORGANICS as reported to SEBI — buying and selling signals from the people who know the business best.
DHAMPUR BIO ORGANICS insider activity below tracks 3 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Deepa Goel | Insider | 31 Dec 2024 | sell | −32.69 L | — | — |
| Vijay Kumar Goel | Insider | 31 Dec 2024 | sell | −3.49 L | — | — |
| Gautam Goel | Insider | 31 Dec 2024 | buy | +36.18 L | — | — |
About DHAMPUR BIO ORGANICS: business, sector, key facts.
What DHAMPUR BIO ORGANICS does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
DHAMPUR BIO ORGANICS operates in the Sugar industry under the Fast Moving Consumer Goods sector, listed as NSE: DBOL, BSE: 543593.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AVADH SUG & ENERGY (AVADHSUGAR) Share PricePeer
- BAJAJ HINDUSTHAN SUGAR LT (BAJAJHIND) Share PricePeer
- BALRAMPUR CHINI MILLS (BALRAMCHIN) Share PricePeer
- BANNARI AMMAN SUGARS (BANARISUG) Share PricePeer
- DALMIA BHARAT SUG IN (DALMIASUG) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about DHAMPUR BIO ORGANICS (DBOL).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of DHAMPUR BIO ORGANICS (DBOL)?
The current share price of DHAMPUR BIO ORGANICS (DBOL) is ₹116.27. Today, the stock has gained by ₹0.46 (0.4%), trading in a range of ₹109.74 to ₹117.30. The stock opened at ₹115.22 with a trading volume of 1,81,653 shares.
02Is DHAMPUR BIO ORGANICS stock a good investment for long-term?
DHAMPUR BIO ORGANICS can be considered for long-term investment based on several factors. The company has a market capitalization of ₹776.73 Cr., P/E ratio of 9.49, ROE of 2.45%, and ROCE of 3.09%. The dividend yield stands at 1.28%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of DHAMPUR BIO ORGANICS stock?
The 52-week high price of DHAMPUR BIO ORGANICS (DBOL) is ₹139.00, while the 52-week low is ₹69.00. Currently trading at ₹116.27, the stock is 68.51% above its 52-week low and 16.35% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy DHAMPUR BIO ORGANICS stock at the current price?
Whether to buy DHAMPUR BIO ORGANICS stock at ₹116.27 depends on multiple factors. The stock is currently trading with a P/E ratio of 9.49 and P/B ratio of 0.78. Today's performance shows a gain of 0.4%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of DHAMPUR BIO ORGANICS and when is the next dividend?
DHAMPUR BIO ORGANICS offers a dividend yield of 1.28%, which means for every ₹100 invested at the current price of ₹116.27, you can expect to receive approximately ₹1.28 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of DHAMPUR BIO ORGANICS?
DHAMPUR BIO ORGANICS's key financial metrics include: P/E Ratio: 9.49, P/B Ratio: 0.78, ROE: 2.45%, ROCE: 3.09%, Dividend Yield: 1.28%, EPS: ₹5.54, Book Value: ₹154.64, and Debt-to-Equity: 1.03. The company's market cap stands at ₹776.73 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is DHAMPUR BIO ORGANICS stock performing today in the market?
DHAMPUR BIO ORGANICS stock opened at ₹115.22 and is currently trading at ₹116.27, showing a gain of ₹0.46 (0.4%). The intraday high is ₹117.30 and low is ₹109.74. The trading volume stands at 1,81,653 shares, indicating moderate market participation today.
08What is the P/E ratio of DHAMPUR BIO ORGANICS and what does it indicate?
DHAMPUR BIO ORGANICS has a Price-to-Earnings (P/E) ratio of 9.49, which means investors are willing to pay 9.49 for every ₹1 of earnings. With an EPS of ₹5.54, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about DHAMPUR BIO ORGANICS (DBOL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.